Related references
Note: Only part of the references are listed.Fc Engineering Approaches to Enhance the Agonism and Effector Functions of an Anti-OX40 Antibody
Di Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodies
Lindsay B. Avery et al.
MABS (2016)
Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy
Geoffrey S. Williams et al.
ONCOTARGET (2016)
Principles of antibody-mediated TNF receptor activation
H. Wajant
CELL DEATH AND DIFFERENTIATION (2015)
Structural basis for binding of human IgG1 to its high-affinity human receptor FcγRI
Masato Kiyoshi et al.
NATURE COMMUNICATIONS (2015)
OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy
Yannick Bulliard et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
Structural Insights into Neonatal Fc Receptor-based Recycling Mechanisms
Vaheh Oganesyan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Structural Determinants of Unique Properties of Human IgG4-Fc
Anna M. Davies et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Immunoglobulin G1 Fc Domain Motions: Implications for Fc Engineering
Martin Frank et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Crystal structure of deglycosylated human IgG4-Fc
Anna M. Davies et al.
MOLECULAR IMMUNOLOGY (2014)
An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations
Omid Vafa et al.
METHODS (2014)
Complement Is Activated by IgG Hexamers Assembled at the Cell Surface
Christoph A. Diebolder et al.
SCIENCE (2014)
Application of human FcRn transgenic mice as a pharmacokinetic screening tool of monoclonal antibody
Kenta Haraya et al.
XENOBIOTICA (2014)
The PDB_REDO server for macromolecular structure model optimization
Robbie P. Joosten et al.
IUCRJ (2014)
Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy
David A. Schaer et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies
Yannick Bulliard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Agonist Anti-Human CD27 Monoclonal Antibody Induces T Cell Activation and Tumor Immunity in Human CD27-Transgenic Mice
Li-Zhen He et al.
JOURNAL OF IMMUNOLOGY (2013)
IgG2 Fc structure and the dynamic features of the IgG CH2-CH3 interface
Alexey Teplyakov et al.
MOLECULAR IMMUNOLOGY (2013)
Correlations between pharmacokinetics of IgG antibodies in primates vs. FcRn-transgenic mice reveal a rodent model with predictive capabilities
Susan H. Tam et al.
MABS (2013)
Engineered antibody Fc variant with selectively enhanced FcRIIb binding over both FcRIIaR131 and FcRIIaH131
F. Mimoto et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2013)
Structural Basis for Enhanced HIV-1 Neutralization by a Dimeric Immunoglobulin G Form of the Glycan-Recognizing Antibody 2G12
Yunji Wu et al.
CELL REPORTS (2013)
Molecular mechanisms of T cell co-stimulation and co-inhibition
Lieping Chen et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity
Timothy S. Fisher et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Apoptotic and antitumor activity of death receptor antibodies require inhibitory Fcγ receptor engagement
Fubin Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
REFMAC5 for the refinement of macromolecular crystal structures
Garib N. Murshudov et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Overview of the CCP4 suite and current developments
Martyn D. Winn et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
An Fcγ Receptor-Dependent Mechanism Drives Antibody-Mediated Target-Receptor Signaling in Cancer Cells
Nicholas S. Wilson et al.
CANCER CELL (2011)
Interaction with FcγRIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody
Ann L. White et al.
JOURNAL OF IMMUNOLOGY (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Inhibitory Fcγ Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies
Fubin Li et al.
SCIENCE (2011)
Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential
Nigel M. Stapleton et al.
NATURE COMMUNICATIONS (2011)
XDS
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates
Kay Stubenrauch et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2009)
Dimers and multimers of monoclonal IgGI exhibit higher in vitro binding affinities to Fcγ receptors
Yin Luo et al.
MABS (2009)
Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcγRIIb with Fc-engineered antibodies
Seung Y. Chu et al.
MOLECULAR IMMUNOLOGY (2008)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1
Shigeki Matsumiya et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease
Stefka B. Petkova et al.
INTERNATIONAL IMMUNOLOGY (2006)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells
F Kanamaru et al.
JOURNAL OF IMMUNOLOGY (2004)
FcγRs modulate cytotoxicity of anti-fas antibodies:: Implications for agonistic antibody-based therapeutics
YY Xu et al.
JOURNAL OF IMMUNOLOGY (2003)
Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity
S Krapp et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Crystal structure of a neutralizing human IgG against HIV-1: A template for vaccine design
EO Saphire et al.
SCIENCE (2001)
Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc
EE Idusogie et al.
JOURNAL OF IMMUNOLOGY (2000)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
